Katherine Stueland, Chief Executive Officer at GeneDx Holdings Corp. (WGS), sold 21,002 shares at $64.77 ($1.4M) on 2025-06-16, disclosed to the SEC on 2025-06-18.
Open-market sale of $1.4M WGS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.77 | 10,501 | $680K | 50.0% |
| 2 | $64.77 | 10,501 | $680K | 50.0% |
| Total | $64.77 avg | 21,002 | $1.4M | 100% |
| Filing → |
| WGS | SELL | 2026-06-18 | $638K | — | Filing → |
| WGS | SELL | 2026-06-11 | $196K | — | Filing → |
| WGS | SELL | 2026-05-01 | $142K | — | Filing → |